Comparison Between Fimasartan Versus Other Angiotensin Receptor Blockers in Patients With Heart Failure After Acute Myocardial Infarction-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison Between Fimasartan Versus Other Angiotensin Receptor Blockers in Patients With Heart Failure After Acute Myocardial Infarction

Published:2023 Issue:25 Volume:38 Page:
ISSN:1011-8934
Container-title:Journal of Korean Medical Science
language:en
Short-container-title:J Korean Med Sci

Author:

Kim Jihoon¹^ORCID,Kang Danbee²^ORCID,Kim Sung Eun³^ORCID,Park Hyejeong²^ORCID,Park Taek Kyu¹^ORCID,Lee Joo Myung¹^ORCID,Yang Jeong Hoon¹^ORCID,Song Young Bin¹^ORCID,Choi Jin-Ho¹^ORCID,Choi Seung-Hyuk¹^ORCID,Gwon Hyeon-Cheol¹^ORCID,Guallar Eliseo²^ORCID,Cho Juhee²^ORCID,Hahn Joo-Yong¹^ORCID

Affiliation:

1. Division of Cardiology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

2. Center for Clinical Epidemiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

3. Division of Cardiology, Inje University Ilsan Paik Hospital, Goyang, Korea.

Funder

Boryung Pharmaceutical Co. Ltd.

Publisher

XMLink

Subject

General Medicine

Link

https://jkms.org/pdf/10.3346/jkms.2023.38.e202

Reference32 articles.

1. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

2. 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

3. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary

4. Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events

5. Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proton Pump Inhibitor for Gastrointestinal Bleeding in Patients with Myocardial Infarction on Dual-Antiplatelet Therapy: A Nationwide Cohort Study;Journal of Epidemiology and Global Health;2024-06-24

2. Optimal Antithrombotic Therapy Beyond 1-Year After Coronary Revascularization in Patients With Atrial Fibrillation;Journal of Korean Medical Science;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3